Assessment of In-Situ Gelling Microemulsion Systems upon Temperature and Dilution Condition for Corneal Delivery of Bevacizumab

Bevacizumab (BVZ), a recombinant humanized monoclonal antibody, has recently been proposed as a topical application in the treatment of anterior segment neovascularization; however, as there are some disadvantages in the administration of common eye-drops, ophthalmic topical drug delivery systems ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Peira, Elena, Chindamo, Giulia, Chirio, Daniela, Sapino, Simona, Oliaro-Bosso, Simonetta, Rebba, Erica, Ivanchenko, Pavlo, Gallarate, Marina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918509/
https://www.ncbi.nlm.nih.gov/pubmed/33668475
http://dx.doi.org/10.3390/pharmaceutics13020258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918509/
https://www.ncbi.nlm.nih.gov/pubmed/33668475
http://dx.doi.org/10.3390/pharmaceutics13020258

Ejemplares similares